Giuseppe Di Gioia
Member of the Editorial Team, PCRonline Editorial Board
Declaration of interest
| Function | Company |
|---|---|
| None |
Latest contributions
What are the essentials of the provisional strategy for non-left main true bifurcation lesions?
21 May 2025 – From EuroPCR 2025
Giuseppe Di Gioia and Jens Flensted Lassen explore the essentials of the provisional stenting strategy for non-left main true bifurcation lesions. This stepwise approach offers simplicity while preserving flexibility: start with one stent in the main vessel, and keep the option open for a second if...
Which valve for which patient? - Part 2: complex anatomy
17 May 2023 – From EuroPCR 2023
Consult this session if you want to understand how to optimize the hemodynamic performance after VinV procedures, to identify patients at risk for coronary occlusion and how to prevent this in VinV procedures, and to learn how to gain safe vascular access in challenging peripheral anatomies.
Innovative coronary approches for your daily practice
20 May 2022 – From EuroPCR 2022
This EuroPCR 2022 session presents innovative types of coronary approches used in different Clinical Case submissions: severe calcific tortuous LAD disease, the calcium challenge or IVUS-guided CTO PCI with minimum contrast...
EuroPCR 2022 Hotlines / Late-Breaking Trials in coronary physiology: DECISION QFR, INOCA, and PROPHET-FFR
17 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in coronary physiology! Angiography-derived coronary microcirculatory assessment in INOCA patients, Heart Team decision-making based on angiography-derived FFR: DECISION QFR, and safety and efficacy of post-PCI physiological assessment: PROPHET-FFR.
Insights from the Corevalve US Pivotal and SURTAVI trials
05 Apr 2022
Pierre Deharo and Giuseppe Di Gioia provide their take on this analysis of the 5 years incidence, outcomes and predictors of hemodynamic SVD in patients undergoing TAVI and surgery from the Corevalve US Pivotal and SURTAVI trials.
Author
Author
PCRonline @ ACC 2022 Scientific Sessions
29 Mar 2022
Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2022 Scientific Sessions #ACC22.
Disrupt CAD III: Safety and effectiveness of intravascular lithotripsy for treatment of severe coronary calcification
17 Oct 2020
At TCT Connect 2020, Dean Kereiakes presented the results of the Disrupt CAD III trial. Giuseppe Di Gioia and Dejan Milasinovic provide a summary of the key messages.
Author
Author
THEMIS - Main results of the effect of Ticagrelor on health outcomes in diabetes mellitus patients intervention study
03 Sep 2019
Author
Author
PCR @ ESC Congress 2019 and the World Congress of Cardiology: the interventional cardiology perspective!
19 Jul 2019
What was new and hot in interventional cardiology at ESC Congress 2019!
PCR's Got Talent - Round 3
23 May 2019 – From EuroPCR 2019
Consult this session to discover the compelling abstracts submitted during the 3rd round of PCR's Got Talent, and presented on-stage during EuroPCR 2019 abstract competition.
PCR's Got Talent - Round 2 - Session 2
22 May 2019 – From EuroPCR 2019
Consult this session to discover the compelling abstracts submitted during the 2nd session of the 2nd round of PCR's Got Talent, and presented on-stage during EuroPCR 2019 abstract competition.
PCR's Got Talent - Round 1 - Session 2
21 May 2019 – From EuroPCR 2019
Consult this session to discover the compelling abstracts submitted during the 1st round of PCR's Got Talent, and presented on-stage during EuroPCR 2019 abstract competition.
